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Pharmaceutical industryObjectives: To describe the IMI EHR4CR project which is designing and developing, and aims to
demonstrate, a scalable, widely acceptable and efﬁcient approach to interoperability between EHR
systems and clinical research systems.
Methods: The IMI EHR4CR project is combining and extending several previously isolated state-of-the-art
technical components through a new approach to develop a platform for reusing EHR data to support
medical research. This will be achieved through multiple but uniﬁed initiatives across different major
disease areas (e.g. cardiovascular, cancer) and clinical research use cases (protocol feasibility, patient
identiﬁcation and recruitment, clinical trial execution and serious adverse event reporting), with various
local and national stakeholders across several countries and therefore under various legal frameworks.
Results: An initial instance of the platform has been built, providing communication, security and
terminology services to the eleven participating hospitals and ten pharmaceutical companies located
in seven European countries. Proof-of-concept demonstrators have been built and evaluated for the
protocol feasibility and patient recruitment scenarios. The speciﬁcations of the clinical trial execution
and the adverse event reporting scenarios have been documented and reviewed.
Conclusions: Through a combination of a consortium that brings collectively many years of experience
from previous relevant EU projects and of the global conduct of clinical trials, of an approach to ethics
that engages many important stakeholders across Europe to ensure acceptability, of a robust iterative
design methodology for the platform services that is anchored on requirements of an underlying Service
Oriented Architecture that has been designed to be scalable and adaptable, EHR4CR could be well placed
to deliver a sound, useful and well accepted pan-European solution for the reuse of hospital EHR data to
support clinical research studies.
 2014 Elsevier Inc. All rights reserved.5th ﬂoor,
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The rapid advancement and availability of health Information
and Communication Technologies (ICT) offers remarkable
enhancement opportunities for the clinical research sector [1].
Electronic health records (EHRs), interconnected through health
care networks, have the potential to interact richly with research
platforms [2]. The EHR in its ideal form for patient care is a
longitudinal record of patient health information generated by
multiple encounters in any care delivery setting. While the
beneﬁts of EHRs in direct patient care are widely recognised,
deriving beneﬁts from the reuse of EHR data through data
warehousing for research purposes is still rare, underestimated
or overlooked [3,4]. In a survey of US academic health centres
only 8% of respondents reported integration of clinical research
data with patient clinical data [5]. If an EHR is fully imple-
mented, reuse of EHR data may be extremely helpful in support-
ing clinical research by reducing redundant data capture,
providing better understanding of real patient populations,
supporting hypothesis testing, checking clinical trial feasibility,
screening populations, supporting patient recruitment and
early detection of safety risks, assessing treatment effectiveness
and outcomes, and conducting post-marketing monitoring and
long-term surveillance [6]. As an example, linking EHRs with
clinical trials has proven to increase the recruitment rate of
patients [7–9].
However, there are many obstacles to be overcome in using
EHRs for clinical research. Fragmentation of patient records and
proprietary health information technology systems that do not
adhere to standards are a challenge. EHR vendors adopt few, if
any, health information standards and very rarely accommodate
controlled terminologies [10]. After evaluation of the numerous
and varying initiatives across Europe, it is apparent that wide-
spread incompatibility of the many data standards currently used
by the clinical research and healthcare communities continues to
hinder the efﬁcient and rapid exchange of data between different
electronic sources and compromises the quality of clinical trial
results. Additional challenges that currently limit the use of, and
value derived from, health ICT solutions in Europe include regional
diversity in languages, healthcare practices and regulations, the
emergence of multiple non-interoperable hospital EHR systems,
and inadequate and inconsistent clinical documentation within
EHRs. These limitations currently prevent the optimal use of EHR
patient level data and information, and impede the advancement
of medical research, the improvement of healthcare and the
enhancement of patient safety [11].
Processes and technologies that meet data privacy and
regulatory requirements, and satisfy other organisational
governance stipulations, are necessary prerequisites to gaining
acceptance of the reuse of EHRs for research [12,13]. Privacy,
legal implications and public relations ramiﬁcations were stated
as concerns by over 80% in a survey [14]. Data quality
(consistency, correctness, completeness) is another challenge
for the reuse of EHR data [15–17]. As a consequence, EHRs
appear to mainly be used currently for non-regulated investiga-
tor-sponsored clinical research and evaluating pilot or prototype
applications [7,10,14,18].
Moving beyond the current state-of-the-art implies setting up a
framework to enable interoperability (encompassing technical,
standards, functional, legal, and organisational aspects) for future
electronic data collection and exchange between systems. This
paper presents the current results of the IMI EHR4CR project which
has designed, developed, and aims to demonstrate, a scalable,
widely acceptable and efﬁcient approach to interoperability
between EHR systems and clinical research systems.2. Background
2.1. Overview of the IMI program
The Innovative Medicine Initiative (IMI) was launched in 2008
by the European Union and the European Federation of Pharma-
ceutical Industries and Associations (EFPIA), with a total budget
of 2 billion Euros to be spent over a 10-year period, making IMI
the largest public–private partnership (PPP) in life sciences R&D.
IMI’s two founding members, EFPIA and the European Union, have
equal investment and rights in the IMI. To fulﬁl its mission, the IMI
implements R&D programs focused on developing new tools and
methods for predicting drug safety and efﬁcacy as well as for more
efﬁcient knowledge management. EFPIA pharmaceutical compa-
nies invest in the IMI in the form of in-kind contributions by com-
mitting internal human resources or providing access to data sets
and infrastructure and sometimes in the form of direct monetary
contributions. This industry investment is matched by funds from
the European Union; the funds support other consortium
members, including academic teams, small and medium-sized
enterprises (SMEs), patient organisations, regulatory agencies,
and relevant not-for-proﬁt institutions. The ﬁrst three calls for pro-
posals, launched by the IMI in 2008, 2009, and 2011, resulted in 30
projects including EHR4CR.
2.2. Overview of the EHR4CR project
The EHR4CR project runs over 5 years (2011–2015) with a
budget of +16 million Euros, involves 34 academic and private
partners (10 pharmaceutical companies) and is to date one of the
largest of the IMI PPPs in this area [19]. This project is developing
adaptable, reusable and scalable solutions (tools and services) for
reusing data from EHR systems for clinical research purposes.
The consortium also includes 11 hospital sites in France, Germany,
Poland, Switzerland and the United Kingdom.
3. Methods
3.1. General overview
The EHR4CR project aims to build a robust and scalable
platform that will unlock data from hospital EHR systems, in full
compliance with the ethical, regulatory and data protection poli-
cies and requirements of each participating country. The EHR4CR
platform supports distributed querying to assist in clinical trials
feasibility assessment and patient recruitment, and will in a later
version also link EHR systems and EHR4CR services to enable clin-
ical researchers to obtain key information about a patient’s health
and healthcare history before they arrive for a screening visit (but
after patient consent has been obtained). Such developments
require securing acceptance from the patients, the public and the
research and health service communities. Therefore, in parallel to
the technical developments, senior level decision makers, ethics
boards and industry executives and scientists, are involved in con-
sultations to provide strategic insights into the most robust and
acceptable technical and procedural approaches that should be
taken to ensure privacy protection and compliance with European
and national/regional regulations on data protection.
The platform is currently being piloted at several hospital sites
across Europe. These sites are themselves active in clinical research
and are able to provide exemplary local governance requirements to
complement the ethical inputs referred to above. To enable wide
adoption by EHR vendors and quality assurance of the EHR4CR plat-
formwithin hospitals, the project also provides governance through
accreditation/certiﬁcation programs for establishing best practices.
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Several tasks are being deployed to research and develop
stakeholder and ethical–legal requirements for the EHR4CR plat-
form and clinical research services. The requirements engineering
process is a sub-process as well as a sub-part of the iterative and
incremental development strategy of the EHR4CR project. The
basic idea is to develop a system through repeated cycles. Starting
with a subset of the software requirements, the system is being
iterated until the full EHR4CR platform is speciﬁed. In each
iteration, design modiﬁcations are made and new functional
capabilities are added. In the ﬁrst step we deﬁned for each iteration
one domain scenario that is used for estimating the probable
effects, as an integral part of situation analysis and long-range
planning and describes the entire domain, e.g. protocol feasibility.
In the next step the domain scenario has been broken down into
high-level ‘Usage Scenarios’ that describe the critical business
interactions (the goals, motivations, inputs, steps, events, and/or
actions which occur during the interaction) with enough detail to
indicate their anticipated operation for the delivery, control and
use of clinical research services. The usage scenarios serve as the
context for the use cases and requirements and allow the teams
to make sure they are complete. Evaluation criteria have also been
deﬁned.
3.3. Technology platform and tools
Based on an inventory of relevant solutions and components
external to the project as well as the internal requirement speciﬁ-
cations, a reference architecture was deﬁned to serve as a technical
speciﬁcation for the construction of a scalable platform supporting
the EHR4CR clinical research services. This EHR4CR platform is
implemented as a common set of components and services that
will allow the integration of the lifecycle of clinical studies with
heterogeneous clinical systems, hereby facilitating data extraction
and aggregation, workﬂow interactions, privacy protection, infor-
mation security, and compliance with ethical, legal and regulatory
requirements. This will help speed up the protocol feasibility
reﬁnement process with rapid feedback on population numbers
and their geographic distribution, assist in identifying suitable
patients via their nominated care providers, speed up and improve
the accuracy of patient recruitment and trial execution, and enable
more complete and real time safety monitoring.
Tools and services are provided to ensure interoperability
between varying and disparate data sources (EHR and EDC
Systems), allowing for the consistent interpretation of data
available from those sources by the EHR4CR end-user services: a
key success factor for the project. A central EHR4CR ‘‘pivot
terminology’’, which is largely based on existing standards such
as ICD10, LOINC, and SNOMED-CT, acts as the principal broker
between heterogeneous terminology systems and is used to
maintain mappings from central (platform-level) concepts to local
(data source-level) concepts and vice-versa [20,21]. The necessary
software applications are being developed to deliver the EHR4CR
clinical research services to end users: clinical protocol feasibility,
patient identiﬁcation and recruitment, clinical trial execution, and
severe adverse event reporting.
3.4. Pilots
The EHR4CR platform is being evaluated by demonstrating the
functionality of the tools and services. These evaluations occur at
several large academic hospitals, interfacing with EHR systems,
with a speciﬁc focus towards a set of medical domains mutuallyagreed between the pilot sites and EFPIA partners. The EHR4CR
project primarily addresses the following disease areas included
in the pilots: oncology, inﬂammatory diseases, neuroscience,
diabetes, cardiovascular and respiratory diseases. These disease
areas are relevant to current pharmaceutical industry pipelines,
and align with clinical research interests and data resources at
the pilot sites. Interfaces between the EHR systems and the
central EHR4CR platform have been established. An inventory of
data elements for pilot studies has been deﬁned. Semantic
mapping between local terminologies and the central EHR4CR ter-
minology has been conducted. Clinical data warehouses (CDWs),
compliant with the EHR4CR platform and the associated extract–
transform–load (ETL) processes have been designed and tested.
Approval of all data processing steps was gained in accordance
with local ethical and legal regulations at each site.4. Results and discussion
4.1. Stakeholders engagement
A detailed analysis has been undertaken of the requirements for
supporting protocol feasibility, patient identiﬁcation and recruit-
ment. The starting point for this was a study through interviews
of protocol managers in order to understand their current work-
ﬂows, and obstacles in undertaking these activities, focusing in
particular on those that contribute to delays in undertaking clinical
trials. Idealised usage scenarios that would take full advantage of a
research platform were then formally documented and used to
develop use cases. As a result of the requirements engineering
process, six usage scenarios for protocol feasibility, 75 use cases
and about 200 requirements were identiﬁed and delivered in a
software requirement speciﬁcation (SRS) document for the
EHR4CR Protocol Feasibility Service. This SRS includes functional
and non-functional requirements. Materials of a similar scale have
now been completed for the EHR4CR Patient Identiﬁcation and
Recruitment Service. These requirements are now informing the
evaluation criteria, which are being developed in collaboration
with the pilot sites.
Early in the project a European electronic survey was under-
taken to better understand the market landscape and help design
a sustainable EHR4CR business model and value propositions.
The survey was conducted in two waves via an online question-
naire (i) with participating stakeholders from the public and pri-
vate sectors involved in the EHR4CR consortium, and (ii) with
non-participating informed stakeholders. The results were highly
consistent between the two groups and conﬁrmed a high level of
interest in the EHR4CR objectives and scenarios, and the relevance
of developing customised value propositions to address the respec-
tive needs of key stakeholders. A scientiﬁc manuscript presenting
the EHR4CR e-survey objectives, methods, results and conclusions
has been published [22].
In order to understand the attitudes and concerns of senior level
stakeholders across Europe to the approaches being developed in
EHR4CR, and therefore to ensure their later support for a Europe
wide EHR4CR deployment, an in-depth survey questionnaire was
developed,with twovariants for ethics andnon-ethics stakeholders.
The questionnaires were developed and initially piloted with 16
interviews undertaken in Scotland, providing the project with some
early and important insights, prior to conducting these as in depth
interviews in ﬁve other European countries. The detailed results of
these interviews will be published later.
Internal EHR4CR policy documents and other written materials
that may be furnished to hospital data protection ofﬁcers have
been developed to support the pilot sites in gaining local approval
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de-identiﬁed sample of patient data to validate the research query
processes.
4.2. Technical platform and tools
An inventory of reusable and available relevant solutions and
components has been compiled with respect to the functional
and non-functional aspects. Examples include middleware, secu-
rity tools, query engines and end-user applications developed by
consortium partners in previous projects such as FARSITE [23]
and ePRCN [24] as well as data querying and analysis tools with
open source license models like i2b2 [25] and SHRINE [26] that
are actively maintained by other organisations or communities.
As an outcome of this effort, software libraries and methodologies
have been re-used and software connectors have been provided
(e.g. offering the possibility to use the EHR4CR reference imple-
mentation with an i2b2 clinical data warehouse).
4.2.1. Information representation
In addition, an inventory of information and knowledge models
has been developed, including terminologies for patient care coor-
dination, information models provided by standards development
organisations for patient care coordination and information mod-
els available from other projects/initiatives.
In the recent past several projects, including eMERGE [27],
i2b2-SHRINE [28], SHARPn [29], OHDSI [30] and the Ofﬁce of the
National Coordinator (ONC) Standards and Interoperability (S&I)
Framework [31,32] and – pilots [33] have developed tools and
technologies that bring out the value of observational health data
through large-scale analytics for decision support and research.
The developed solutions allow identifying patient cohorts and
extracting patient-centric data using distributed EHRs/CDWs for
deﬁned purposes, including case–control cohorts for genome-wide
association studies or pharmacogenetic studies, feasibility studies
and patient recruitment in clinical trials, adverse event detection
or quality metrics calculation.
In this context, ‘‘phenotyping algorithms’’ are deﬁned in order
to compute eligibility criteria for identifying patient cohorts and
to collect patient-centric data of interest. ‘‘Phenotyping algo-
rithms’’ are typically represented as pseudocode with varying
degrees of formality and structure [29,34].
The algorithmic patient cohort identiﬁcation and data extrac-
tion within EHRs/CDWs is based on query speciﬁcation involving
EHR/CDW data ﬁelds (e.g., diagnoses, procedures, laboratory
results, and medications) and logical operators. Clinical statements
in the query speciﬁcation expressed in the clinical research Model
of Use ﬁrst need to be deﬁned using Common Data Elements of the
Model of Meaning and then transformed into local-EHR-speciﬁc
Model of Use to be executed within EHRs/CDWs.
A semi-formal representation of eligibility criteria has been
developed which was used to identify a core set of data elements
that cover an important part of patient-level inclusion and exclu-
sion criteria. The EHR4CR semantic resources integrate a range of
clinical models linked to clinical terminologies that are needed to
collectively represent the variety of clinical statements (including
diagnosis, ﬁndings, familial and medical history, lab tests, medica-
tion, etc.). The layering of the EHR4CR information model is based
on (i) a generic reference information model i.e. the ISO/HL7 21731
Version 3 Reference Information Model (RIM), (ii) more detailed
information models i.e. the Common Element Templates (CETs)
and Common Data Elements (CDEs) speciﬁed consistently with
ISO/IEC 11179 Metadata Registry (MDR) standard [35] and
with the ISO 21090 Healthcare Data Types [36] and (iii) clinical
terminology models such as ICD or SNOMED-CT.The set of EHR4CR Common Element Templates (CETs) and
Common Data Elements (CDEs) that instantiate generic reference
models and are tailored to the needs of structured data acquisition
(e.g. HL7’s Clinical Document Architecture (CDA) meta-standard
and the derived Continuity of Care Document (CCD) and Consoli-
dated Clinical Document Architecture (C-CDA)).
EHR4CR Common Element Templates (CETs) and Common Data
Elements (CDEs) can be considered as the semantic building blocks
of the EHR4CR Common Information Model, of which each interop-
erating applications should be aware. EHR4CR Semantic Resource
Repository provides to EHR4CR components and interoperating
applications machine-processable deﬁnitions of CETs and CDEs
that they can consume through semantic services during both
query speciﬁcation at workbench and query execution at endpoint.
Semantic services are essential, and were developed according
Common Terminology Services 2 (CTS2) functional speciﬁcation
that needed to be extended.
Semantic annotation of these data elements (and of the con-
cepts of their value sets) has been undertaken based on reference
terminologies integrated in the EHR4CR pivot terminology. The
ﬁrst version of the HL7 RIM-based EHR4CR information model (a
platform-independent conceptual model) is now complete and
its relationship with other reference information models such as
CDISC/HL7 BRIDG (Biomedical Research Integrated Domain
Group), a domain analysis model for the clinical research domain
serving to link healthcare and research [37] or Observational
Medical Outcomes Partnership (OMOP) Common Data Model [38],
a standard format of observational data accessed in the context
of drug safety analysis, are currently documented.
The EHR4CR semantic models, resources & semantic tools are
available at [39].
4.2.2. Platform services
An EHR4CR platform architecture description has been devel-
oped and has been iteratively reﬁned and extended. This has
ensured that important concerns have been addressed by the
architecture and has established a common understanding
amongst the EHR4CR development teams. The platform is based
on a Service Oriented Architecture (SOA) into which service
providers and consumers can dynamically connect. As such, the
primary goal of the EHR4CR architecture description is the speciﬁ-
cation of clearly deﬁned interfaces and component responsibilities
while the physical location of service consumers and providers is
only of secondary importance. The key EHR4CR services and their
behaviour are described in Table 1.
Data endpoints are key services in the EHR4CR platform from
which the different scenarios can be built up. Given their impor-
tance and complexity, they are a particular focus of the EHR4CR
architecture description. Fig. 1 provides a simpliﬁed view of the
EHR4CR platform, focusing on the data endpoints.
4.2.3. Data endpoint (hospital) services
The access to the clinical data locally at the data endpoints con-
sists of three logical layers: the legacy system layer (speciﬁc to the
type of CDW or EHR used by the local site), the Legacy Interface
layer (for accessing the local CDW or EHR) and the EHR4CR Data
source Endpoint layer (generic layer used by all the EHR4CR com-
patible data endpoints). The Legacy Interface layer deals with the
complexity involved when accessing the various types of CDW
and EHR systems used and the adopted strategy for translating
queries against the EHR4CR information model and pivot terminol-
ogy into queries that can be executed locally against the CDW or
EHR system. The EHR4CR Data source Endpoint layer is a generic
layer that exposes uniform EHR4CR endpoint interfaces to other
EHR4CR services and components and allows for plugging in
Table 1
Key EHR4CR services.
Service Category Description
Registry service Infrastructure Allows publishing and inquiring the technical capabilities and organisation-level metadata of a (data provider) site
exposing applications or services on the platform
SSO service Security Provides single-sign on for end-users to platform applications
Security token service Security Authenticates clients of platform (Web) Services. Also supports credential delegation allowing applications to act as
end-users, thus allowing them to invoke services on their behalf with full traceability
Identity management
service
Security Allows managing platform users and their organisations
Message broker Infrastructure Allows data providers to interact with platform applications without having to expose their Web Services on the
Internet
Terminology service Semantic
interoperability
Allows querying for central information model concepts (data elements, terminologies and value sets) and their
relationships
Used for query speciﬁcation at Workbench (accessing central codes from reference terminologies to specify canonical
queries)
Used for query execution at endpoint (transcoding central to local codes in queries and vice-versa in results)
Terminology mapping
service
Semantic
interoperability
Allows mapping central terminology elements and value sets to their local counterpart(s) and vice-versa
Eligibility criteria query
service
Querying Allows executing protocol feasibility queries and retrieving their results
Patient recruitment service Workﬂow Web Service exposed by a sponsor for receiving a clinical site’s study participation status and recruitment status
updates
Patient recruitment
participation service
Workﬂow Web Service exposed by a clinical site for receiving study participation requests and study status updates
Fig. 1. Simpliﬁed view of the EHR4CR platform.
Table 2
Major standards on which the EHR4CR security architecture is based.
Standard URL Use
SOAP http://www.w3.org/TR/soap/ Required for all secure web service interactions
WS-Security v1.1 https://www.oasis-open.org/committees/
tc_home.php?wg_abbrev=wss
Required for achieving secured messaging between EHR4CR service providers
WS-Trust v1.4 http://docs.oasis-open.org/ws-sx/ws-trust/v1.4/
errata01/ws-trust-1.4-errata01-complete.html
Obtaining security tokens from a platform-governed security service to allow
establishing, assessing and brokering trust relationships between EHR4CR service
providers
SAML v2 http://saml.xml.org SAML web SSO proﬁle for end-user authentication. Use of SAML v2 tokens for identity
federation and platform-level authorisation
SAML V2.0 Condition for
Delegation
Restriction
http://docs.oasis-open.org/security/saml/
Post2.0/sstc-saml-delegation-cs-01.pdf
Mechanism for specifying delegation credentials
SAML 2.0 Proﬁle of
XACML, version 2.0
http://docs.oasis-open.org/xacml/3.0/xacml-
proﬁle-saml2.0-v2-spec-cs-01-en.pdf
Mechanism for requesting authorisation decisions from a platform-governed
authorisation service and for requesting attribute assertions from Attribute Authorities
in order to evaluate access control policies
166 G. De Moor et al. / Journal of Biomedical Informatics 53 (2015) 162–173various local application modules for the different functional sce-
narios tackled within EHR4CR. The EHR4CR Data source Endpoint
layer encompasses a generic EHR4CR Data Mart (DM) componentthat is used in case an ETL strategy has been adopted within the
Legacy Interface layer. The EHR4CR DM is a direct physical
representation of the EHR4CR information model. These layers
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required (e.g. invoking a measurement conversion service)
(Fig. 1). The EHR4CR Data source Endpoint reference implementa-
tion that has been developed in the EHR4CR project assumes an
underlying SQL-based data warehouse and uses a system of query
templates for translating individual criteria to queries against the
local physical information model. It relies on a terminology map-
ping service for dynamically translating between concepts
expressed using the pivot terminology and local terminologies. It
contains capabilities for converting to and from UCUM measure-
ments or for converting coded concepts to and from their corre-
sponding rank in stages or scores (e.g. ECOG scores or TNM stages).
In order to be able to interact with other platform users and ser-
vices, service providers (and in particular data providers) must
adhere to the technical interfaces and support information
exchange based on the information models. Additionally, they
may need to support service-provider speciﬁc requirements. Once
approved, the service provider metadata is added to the central
registry and exposed services and applications can be published
so that platform users can discover them.
4.2.4. Platform architecture for PFS and PRS
The current architecture description focuses on the Protocol
Feasibility Scenario (PFS) and Patient identiﬁcation and Recruit-
ment Scenario (PRS). The main components involved in the proto-
col feasibility scenario are (see Fig. 2):
 Protocol feasibility tools in the form of a workbench for study-
ing non-identiﬁable distributed patient data. Note that these
tools focus on authoring and managing (computable) eligibility
criteria queries rather than providing functionality for clinical
trial protocol authoring.
 An orchestration module allowing distributed execution of
eligibility criteria queries.
 Endpoint (data access) services allowing eligibility criteria
query execution on local clinical data warehouse facilities.Fig. 2. Overview of the main services o Supporting semantic interoperability services (e.g. coding sys-
tem value mapping), registry services (e.g. for dynamically dis-
covering query endpoints), a message broker and security
services (e.g. single sign-on).
In the PFS scenario, EHR4CR avoids issues related to patient
informed consent as no individual patient-level information is
being exchanged (i.e. leaves the hospital site), only aggregated
numbers according to demographic categories. Additional mea-
sures such as data perturbation and generalisation have been
built into avoid potential patient re-identiﬁcation from aggre-
gated results.
For the patient identiﬁcation and recruitment scenario, the
EHR4CR platform has been extended in the following ways:
 The workbench designed and developed for the PFS has been
extended to support coordination and monitoring of the recruit-
ment process.
 New patient identiﬁcation and recruitment tracking tools have
been made available to the clinical sites in the form of a work-
bench application for relationship management with clinical
trial sponsors, local study management and patient identiﬁca-
tion and recruitment status tracking. Each participating clinical
site has its own installation only to be used locally. Supporting
endpoint (data access) services allow eligibility criteria query
execution for composing the initial set of candidate patients
for recruitment (to be assessed by a human investigator).
Re-identiﬁcation services locally allow authorised treating
physicians to see the patient identifying information corre-
sponding to a candidate record in order to allow getting into
contact with the patient to initiate the recruitment process.
 Secured web services at both ends (local and central work-
benches) allow exchanging the necessary information (such as
accrual rates, but not patient identiﬁable information) to steer
the recruitment processes at the sponsor site and each of the
individual clinical sites.f the protocol feasibility scenario.
Fig. 3. Patient recruitment status tracking and privacy.
Fig. 4. Sequence diagram for PFS query execution.
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not exposing patient-level information outside the environment
of the clinical sites (Fig. 3). On the local level (within each clinical
site), the PRS services support the most stringent requirements
encountered amongst the consortium’s pilot sites, requiring for
instance that a treating physician (or an equivalent role by conﬁg-
uration) notiﬁes each patient who is a potential candidate for
recruitment and obtains the patient’s approval before handing over
the patient’s personally identiﬁable information to a research
investigator for further follow-up. The solution is based on a con-
ﬁgurable workﬂow system that allows for customisation accordingto local rules and policies. For example, the assignment of the per-
son or group to initially contact a potential candidate patient can
be based on departmental information recorded in the clinical data
warehouse or other information sources. In addition, tracking of
obtained informed consent is an explicit step in the patient’s
recruitment status tracking system.
Viability of the initial EHR4CR architecture has been shown in
the form of a PFS demonstrator incorporating reference implemen-
tations of the various platform tools and services described by the
architecture and data endpoint instances hosted by the EHR4CR
partners contributing to the pilot activities (see below).
Fig. 5. PFS query builder graphical user interface.
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involved in the PFS demonstrator while Fig. 4 shows themain inter-
actions. The process of querying individual data endpoints for pro-
tocol feasibility is initiated by the workbench instance on behalf of
an end-user. The workbench then submits a series of Eligibility
Criteria (EC) queries to an orchestrator service instance. The
orchestrator instance identiﬁes and invokes the data endpoints to
which the EC queries are targeted. Finally after receiving the indi-
vidual EC query results (number of eligible patients at each site),
the orchestrator service instance provides a consolidated result to
the workbench instance which will eventually be displayed to the
end-user. Discovery of the involved endpoints and their location
is provided by a set of registry services. Transformation between
EC against the EHR4CR information model and terminologies and
local models and terminologies is provided by a number of seman-
tic services. Finally, a number of platform-level authentication and
authorisation services provide a uniform securitymodel and ensure
compliance with the EHR4CR security architecture (Fig. 2).Fig. 6. Screenshot of4.2.5. Clinical research workbench and workﬂow
The PFS demonstrator includes a workbench application that
allows the authoring and execution of computable Eligibility Crite-
ria (EC) queries and allows secured sharing of feasibility studies
and the associated EC queries amongst different platform users.
EC queries can be built using a user-friendly graphical user inter-
face which allows specifying Boolean and temporal constraints
between individual EC (Fig. 5) (see also [40] for more details).
After running an EC query, the results can be visualised by
showing the overall results with the possibility to access break-
downs on the patient demographics (age categories and gender)
level, the individual eligibility criterion level as well as the results
returned by the individual sites (Fig. 6).
For the PRS this workbench has been extended to include
recruitment study coordination functions and a corresponding
dashboard showing the current recruitment and accrual status at
each of the clinical sites that have been invited to participate in a
given study.a query result.
Fig. 7. Flow between the PRS components (the dark blue components have been re-used from the PFS scenario and the light blue components have been added to support the
PRS demonstration project). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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components (Fig. 7).
In order to start the recruitment process for a given study, a
new study deﬁnition must be created by the study manager. The
deﬁnition includes the protocol description and optionally the for-
mal eligibility criteria to allow computer-assisted checking of
patient eligibility. The study deﬁnition can be based on an existing
study deﬁnition previously created through the PFS or it can be
newly created if protocol feasibility checking for the given study
has not been previously conducted on the platform. The study def-
inition can also be based on an existing CDISC SDM (Study Design
Model) ﬁle. The formal eligibility criteria deﬁned for the PFS can be
extended and enhanced to be used for the PRS.
Through the registry service, the study manager is able to select
clinical sites of interest that expose the necessary technical inter-
face. Following this an invitation containing the study deﬁnition
will be sent to each of the selected sites. The study deﬁnition will
be imported in the local study repository and the invitation will
eventually be presented to the data relationship manager responsi-
ble for engaging the clinical site in semi-automated studies.
Once a clinical site has been invited to participate in a given
study for recruitment, its participation status will be visible to
the study manager. Once the clinical site accepts to participate,
the number of patients in each of the various recruitment stages
will be periodically made available to the study manager (Fig. 8).
For the clinical sites, an entirely new application has been
designed and implemented to support data relationship manage-
ment (participations in clinical studies), local study management
(user assignments and study status) and candidate patient identi-
ﬁcation and patient recruitment status tracking. After the siteaccepts to participate in a given study, the Principal Investigator
can create a selection containing potential candidate patients to
be recruited. If the study participation request includes a formal
representation of the EC, these can be used at the clinical site to
automatically query the data access endpoint to populate the ini-
tial list of (potential) candidate patients (computer-assisted candi-
date selection). The initial candidate patient list will be based on
pseudonimised records and patient identifying information will
not be visible until a treating physician has contacted the patient
and if the patient agrees to enter the enrollment process.
The overall distributed workﬂow between study manager (cen-
tral workbench) and the users at the clinical site (local workbench)
is depicted in the following diagram (Fig. 9):
4.2.6. Security architecture
The EHR4CR security architecture is an important part of the
overall architecture. It speciﬁes a set of proﬁles that must be
adhered to by EHR4CR-compliant tools and services in order to
securely engage with one another. These proﬁles have been deﬁned
by selecting a number of existing security standards and by deﬁning
a number of restrictions on their use to achieve interoperability.
Next to this, the EHR4CR security architecture also mandates the
adoption of a number of information security practices (e.g.
regarding the treatment of passwords and personal medical data)
as mandated by the EHR4CR non-functional requirements. Table 2
mentions the most important security standards on which the
EHR4CR security architecture is based.
This security architecture was chosen over other solutions given
the maturity of the standards on which it is based, the level of soft-
ware industry adoption, the availability of tools and development
Fig. 8. Screenshot of the clinical site recruitment status dashboard.
Fig. 9. Overall distributed workﬂow.
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overall EHR4CR architecture and the familiarity of the EHR4CR
security work package team with the above standards.
The EHR4CR security architecture has been selected to provide a
number of state-of-the-art capabilities to deal with challenging
security concerns. This includes the ability to enforce (potentially
site speciﬁc) access control policies against the identity and char-
acteristics (e.g. afﬁliation or geographic location) of the end-user
on whose behalf EC queries have been issued even though the
end-user is not invoking the data endpoints directly. In order to
achieve this, the EHR4CR authentication and authorisation services
support standard-based constrained delegation of credentials
[41,42].
In order to encompass existing local data provider security pol-
icies and ﬁrewall rules, the platform supports the invocation of
web services using dynamically conﬁgurable transport bindings.
Examples include asynchronous web service invocation byemploying message-oriented middleware to provide the ability
(from an endpoint provider perspective) to retrieve (pull) incoming
queries rather than receiving these directly (push), thus avoiding
the need for endpoint providers to accept incoming connections
from the Internet into their local network. This feature ensures
compliance with local data provider policies, thus facilitating
platform adoption, while at the same time allowing for stan-
dards-based authentication and authorisation of end-users and
web service clients operating on their behalf (Fig. 10).4.3. Pilots
A top list of data elements containing 75 EHR data elements has
been identiﬁed by comparing common eligibility criteria used by
EFPIA partners at the pilot sites with available data elements in
the EHR/CDW and EDC systems. In addition, a wish-list has been
Fig. 10. Classical ‘‘trust’’-based inter-service authentication vs. delegation-based
authentication.
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more than 50% of the sites but deemed important [43].
Currently, all pilot sites have installed a local endpoint with
connection to a local clinical data warehouse, and eleven data pro-
vider sites in ﬁve countries are connected to the EHR4CR platform.
With regard to the protocol feasibility scenario, the proof-
of-concept demonstrator has been tested using feasibility queries
from twelve different clinical trials. All EFPIA partners participated
in this user acceptance test. Overall, 373 free-text eligibility criteria
were reviewed by clinical trial experts. 175 feasibility criteria were
transformed into a computable representation. Pilot sites mapped
approximately 300 codes from their local terminologies into the
central EHR4CR terminology, for instance taking into account dif-
ferent national coding systems for medical procedures.
Evaluation of PFS will compare the number of patients counts
reported using traditional feasibility methods vs. patient counts
obtained through EHR4CR platform, vs. manual count of eligible
patients obtained through manual review of patient ﬁles.
With regard to the patient recruitment and identiﬁcation sce-
nario, ﬁfteen trials have been identiﬁed by the EFPIA partners.
Work has been undertaken in order to simplify their eligibility cri-
teria. Evaluation of the PRS will take place by comparing patient
lists and counts by two distinct methods (obtained through tradi-
tional recruitment methods vs. obtained through searching and
identiﬁcation of the EHR4CR platform).
5. Conclusion
This paper has described the rationale and methodology of the
EHR4CR project and provided a detailed description of the ﬁrst two
services that have been implemented: for protocol feasibility and
for patient identiﬁcation for recruitment. The consortium is now
working to implement further scenarios for linking EHR data to
the EDC systems used to conduct clinical trials, to reduce the dupli-
cation and errors when pre-existing clinical information is re-
entered during a trial and also for using this link to help better
detect serious adverse events to trial medication. These service
speciﬁcations will be published later.
Through a combination of a consortium that brings collectively
many years of experience from previous relevant EU projects and
the global conduct of clinical trials, an approach to ethics that
engages many important stakeholders across Europe to ensure
acceptability, a robust iterative design methodology for the plat-
form services that is anchored on requirements and an underlying
Service Oriented Architecture that has been designed to be scalable
and adaptable, EHR4CR could be well placed to deliver a sound,
useful and well accepted pan-European solution for the reuse of
hospital EHR information to support clinical research studies.Consequently, EHR4CR could play a role in the discovery of new
knowledge from health data, as well stimulate the ability of hospi-
tals to promote excellence in documenting patients records in their
EHRs.
By the end of this project there are clear expectations that the
EFPIA companies and hospital partners involved in EHR4CR will
be the ﬁrst to become accredited members of the EHR4CR network.
By making the EHR4CR project deliverables and speciﬁcations pub-
licly available, as well as through a non-proﬁt European Institute
for Innovation through Health Data, the intent is to attract new
actors to join this network. This may include in the future other
providers of EHR4CR services and possibly alternative implemen-
tations of the platform itself, although these will also be required
to be certiﬁed according to a common conformance standard.
The organisational model, with inclusion of an independent
Trusted Third Party (TTP), will also allow for additional kinds of
data transactions between different stakeholders and environ-
ments (including e.g. platform-level audit trail (re)construction
and speciﬁc (de-identiﬁed) data exchanges outside the scope of
the standard scenarios). Through the envisaged European Institute
for Innovation through Health Data, pharmaceutical companies
will be encouraged to continue to collaborate pre-competitively
to evolve the EHR4CR services to meet new needs, and to acceler-
ate and improve the quality of clinical research.
The project could enable a scalable and ﬂexible approach to
reusing EHR data which can bring safe and effective innovative
medicines more quickly to the market and enrich medical research
and knowledge. Encouragingly, top-down change is happening in
tandem with bottom-up capability (i.e. EHR systems and the rich-
ness of EHRs are improving so that EHR4CR like solutions can suc-
ceed). Where regulatory authorities have historically been slow to
evolve, a more welcoming approach to innovation is on the cards.
As these approaches take shape, the stage is set for an efﬁcient clin-
ical research experience: one in which the design is better suited to
a ﬁeld undergoing constant transformations and shake-ups. For the
industry, this will provide innovative integrated and efﬁcient solu-
tions. For patients, it will reveal to be a genuine revolution.
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